Physician profile
Daniel K Moon
NPI 1437388543
$6,603.85
in general payments reported to CMS, 2019-2025
9 companies · $501 in 2025
The $501 reported for 2025 was more than what 79% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2021: $3,075 · 2022: $614 · 2023: $660 · 2024: $1,651 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,754 · Travel and Lodging: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,753.99 |
| Travel and Lodging | $1,057.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $3,178.86 | 2019-2025 | Dysport |
| Pacira Pharmaceuticals Incorporated | $1,545.62 | 2024-2025 | Zilretta, Iovera |
| Merz Pharmaceuticals, LLC | $801.23 | 2022-2025 | Xeomin |
| Medtronic, INC. | $700.36 | 2022-2023 | Signia, Ligasure |
| Spr Therapeutics, INC | $219.84 | 2021-2023 | Sprint Pns System |
| Abbvie INC. | $63.38 | 2025 | |
| Boston Scientific Corporation | $41.45 | 2025 | Wavewriter Alpha Prime 16 |
| Davol INC. | $36.11 | 2025 | Phasix Mesh |
| Cadwell Industries, INC | $17.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.